The pres, does mention it
"Sozinibercept is being developed for use in combination with any of the existing anti-VEGF-A agents, biosimilars, or novel therapies in development for wAMD...The $15bn global market comprised of Eylea, Vabysmo, Lucentis revenue plus an estimate for biosimilars, Avastin off-label, and Beovu of ~$1bn"
- Forums
- ASX - By Stock
- Ann: Trading Halt
The pres, does mention it"Sozinibercept is being developed for...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $398.3M |
Open | High | Low | Value | Volume |
36.5¢ | 38.5¢ | 35.5¢ | $685.8K | 1.856M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 61550 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 48038 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 287 | 0.365 |
3 | 28252 | 0.360 |
5 | 252553 | 0.355 |
11 | 360315 | 0.350 |
4 | 51105 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 50000 | 1 |
0.380 | 16000 | 2 |
0.385 | 96007 | 2 |
0.390 | 7694 | 2 |
0.395 | 5000 | 1 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online